Frances Rudnick Levin MD
Addiction
Associate Professor of Psychiatry, Columbia P&S
Request Appointment
1051 Riverside Drive, Box 66NYSPI, Dept Psychiatry-RFMHNew York, NY 10032
Overview of Dr. Levin
Dr. Frances Levin is a psychiatrist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital, NewYork-Presbyterian/Columbia University Irving Medical Center, and Mount Sinai Morningside. She received her medical degree from Weill Cornell Medicine and has been in practice 39 years. She is one of 956 doctors at New York-Presbyterian Hospital and one of 281 doctors at Mount Sinai Morningside who specialize in Psychiatry. She has more than 100 publications and over 500 citings.
Education & Training
University of Maryland Medical CenterResidency, 1989 - 1990
New York-Presbyterian HospitalResidency, 1985 - 1988
Weill Cornell MedicineClass of 1985
Certifications & Licensure
NJ State Medical License 2004 - 2027
NY State Medical License 1986 - 2026
MD State Medical License 1988 - 1992
American Board of Psychiatry and Neurology Psychiatry- American Board of Psychiatry and Neurology Addiction Psychiatry
Awards, Honors, & Recognition
- New York Magazine: Top Doctors Castle Connolly, 2011-2014
- Top Doctors: New York Metro Area Castle Connolly, 2007-2014
Clinical Trials
- Treatment of Adult Attention Deficit Hyperactivity Disorder (ADHD) in Methadone Patients - 1 Start of enrollment: 1998 Feb 01
- HIV Counseling Intervention for Methadone-Maintained Patients - 2 Start of enrollment: 1999 Oct 01
- Free Venlafaxine Treatment for Marijuana Addiction and Depression - 1 Start of enrollment: 2004 Mar 01
Publications & Presentations
PubMed
- Predictors of treatment success in patients with substance use disorder (SUD) and co-morbid attention deficit/hyperactivity disorder (ADHD): Results from the Internati...Christoffer Brynte, Arnt Schellekens, Maija Konstenius, Alex Hendrikus Abraham Begeman, Cleo Lina Crunelle
European Neuropsychopharmacology. 2026-02-06 - The impact of the communities that HEAL intervention on the provision of jail-based medication for opioid use disorder & linkage programs at release: Results from a ra...Carrie B Oser, Joel G Sprunger, Tim Hunt, JaNae Holloway, Redonna K Chandler
Journal of Substance Use and Addiction Treatment. 2026-02-01 - Medical Cannabis and Opioid Receipt Among Adults With Chronic Pain.Deepika E Slawek, Chenshu Zhang, Stephen Dahmer, Nancy Sohler, Yuval Zolotov
JAMA Internal Medicine. 2026-02-01
Press Mentions
Older Adults with ADHD More Likely to Be Overlooked for Diagnosis, TreatmentSeptember 21st, 2023- Effort Underway to Develop First US Guidelines for ADHD in AdultsApril 17th, 2023
- AELIS FARMA : Announces a Strategic Collaboration and Option-License Agreement with INDIVIOR for the Treatment of Cannabis-Related DisordersJune 8th, 2021
Grant Support
- Translational Clinical Research Fellowship on Substance Use DisordersCOLUMBIA UNIVERSITY HEALTH SCIENCES1993–2028
- Translational Clinical Research Fellowship on Substance Use DisordersCOLUMBIA UNIVERSITY HEALTH SCIENCES1993–2028
- Augmenting cognitive-behavioral therapy with rTMS of the medial prefrontal and anterior cingulate cortices for the treatment of cocaine use disorderNEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC2023–2026
- Phase 1 and 2 studies of sublingual dexmedetomidine, an alpha 2 adrenergic agonist, for treating opioid withdrawalNEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC2022–2025
- Development of PPL-138, a Novel Mixed NOP/Mu Partial Agonist for Treatment of CocaineUse DisorderPHOENIX PHARMALABS, INC.2022–2025
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
